SPY335.84-2.98 -0.88%
DIA279.57-1.46 -0.52%
IXIC10,910.28-140.19 -1.27%

JP Morgan Initiates Coverage On TG Therapeutics with Overweight Rating, Announces Price Target of $38

JP Morgan initiates coverage on TG Therapeutics (NASDAQ:TGTX) with a Overweight rating and announces Price Target of $38.

 · 
JP Morgan initiates coverage on TG Therapeutics (NASDAQ:TGTX) with a Overweight rating and announces Price Target of $38.